abstract |
Disclosed is a pharmaceutical delivery device comprising synthetic prostaglandin PGE1 analogue in a polyurethane hydrogel, wherein the hydrogel has a water content of less than 1% by weight. Preferably the delivery device is in the form of a suppository, or vaginal pessary, a buccal insert or an implant. |